Hatim Kara

• I am a motivated and interpersonal savvy with strong clinical learning agility scientific researcher with 6 years of collective experience working with oncology and neurology in clinical research organizations and scientific research. Knack for communicating clinical data and utilizing scientific evidence to achieve improved patient care.
• Having gained extensive knowledge in oncology and neurology and developed strong rapport and collaborative relationships with healthcare professionals to ensure accelerated progression in healthcare allowing skilled interpretation and communication of clinical data to clinicians and scientists.
• I am excited to a transition to an MSL role as it will enable thorough utilization of communication skills and scientific expertise in a medical affairs role. I am confident that my extensive scientific expertise combined with my communication skills will enable effective development of collaborative peer to peer relationships with KOLs and collect medical insights that will define, update, and support medical strategies within this esteemed organization.

• Initiated a detailed discussion with an international KOL that resulted in collaboration potential for future therapeutic research.
• Developed a collaboration with a local KOLs and clinicians which resulted in access to patient history leading to improvised strategies to deliver best healthcare.

• Strong understanding of clinical trial design obtained from completing Pragmatic Clinical Trial Course from MD Anderson Cancer Center in Houston, Texas.

• Strong understanding of ABPI code of practice, PHRMA code & The Sunshine Act, FSA, Innovative medicine Code of Practice and its implications for MSLs working in the pharmaceutical industry in UK, USA, Germany and Canada.
• Adept at KOL stakeholder mapping.
• Familiar with CRM systems such as Veeva.

• Presented my research findings at 7 national and 3 international conferences to an audience of clinicians, researchers and scientists resulting in robust scientific discussions after my talk.
• Performed critical appraisal of clinical papers and presented at weekly journal club to my colleagues resulting in experience answering scientific questions.
• Presented my research findings and utilized my knowledge of peer-reviewed publications to answer questions from national and international scientists and clinicians resulting in improved therapeutic outlook.
• Active member of a local toastmaster club leading to improved professional communication.

• Recognized a gap in the market and developed a side business offering one-on-one/group tutelage to school level science students enabling them to succeed in final year exams.
• Successful completion of Strategic Planning Foundation course resulting in understanding of SWOT analysis and its implications in the pharmaceutical environment.

References available upon request